APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gadopentetate Dimeglumine API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Gadopentetate Dimeglumine API Industry Growth and Trends Forecast to 2032

Report ID 173993830127 December 202599 pages

Choose your research edition.

Industry ResearchGadopentetate Dimeglumine API Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gadopentetate Dimeglumine API Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Gadopentetate Dimeglumine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gadopentetate Dimeglumine API Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gadopentetate Dimeglumine API Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gadopentetate Dimeglumine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gadopentetate Dimeglumine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gadopentetate Dimeglumine API include Shanghai New Hualian Pharmaceutical, Seven Star Pharmaceutical, Guangdong Xianqiang Pharmaceutical, Beijing Beilu Pharmaceutical and Biophore, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Gadopentetate Dimeglumine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Gadopentetate Dimeglumine API market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Gadopentetate Dimeglumine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Gadopentetate Dimeglumine API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Gadopentetate Dimeglumine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Gadopentetate Dimeglumine API Market by Company

Shanghai New Hualian Pharmaceutical

Seven Star Pharmaceutical

Guangdong Xianqiang Pharmaceutical

Beijing Beilu Pharmaceutical

Biophore

Gadopentetate Dimeglumine API Segment by Type

Purity ≥98%

Purity ≥99%

Gadopentetate Dimeglumine API Segment by Application

CNS Contrast Agent

Liver Contrast Agent

Others

Gadopentetate Dimeglumine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gadopentetate Dimeglumine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gadopentetate Dimeglumine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gadopentetate Dimeglumine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Gadopentetate Dimeglumine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Gadopentetate Dimeglumine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≥98% Table 2. Major Company of Purity ≥99% Table 3. Global Gadopentetate Dimeglumine API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (Tons) Table 5. Global Gadopentetate Dimeglumine API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Gadopentetate Dimeglumine API Sales Market Share in Value by Type (2021-2026) Table 8. Global Gadopentetate Dimeglumine API Price by Type (2021-2026) & (US$/K G) Table 9. Global Gadopentetate Dimeglumine API Sales by Type (2027-2032) & (Tons) Table 10. Global Gadopentetate Dimeglumine API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Gadopentetate Dimeglumine API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Gadopentetate Dimeglumine API Sales Market Share in Value by Type (2027-2032) Table 13. Global Gadopentetate Dimeglumine API Price by Type (2027-2032) & (US$/K G) Table 14. North America Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (Tons) Table 15. North America Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (Tons) Table 17. Europe Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (Tons) Table 21. Latin America Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Gadopentetate Dimeglumine API Sales by Type (2021-2026) & (US$ Million) Table 24. Gadopentetate Dimeglumine API Industry Trends Table 25. Gadopentetate Dimeglumine API Industry Drivers Table 26. Gadopentetate Dimeglumine API Industry Opportunities and Challenges Table 27. Gadopentetate Dimeglumine API Industry Restraints Table 28. Global Gadopentetate Dimeglumine API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Gadopentetate Dimeglumine API Revenue Market Share by Company (2021-2026) Table 30. Global Gadopentetate Dimeglumine API Sales by Company (2021-2026) & (Tons) Table 31. Global Gadopentetate Dimeglumine API Sales Share by Company (2021-2026) Table 32. Global Gadopentetate Dimeglumine API Market Price by Company (2021-2026) & (US$/K G) Table 33. Global Gadopentetate Dimeglumine API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Gadopentetate Dimeglumine API Major Company Production Sites and Headquarters Table 35. Global Gadopentetate Dimeglumine API Company, Product Type & Application Table 36. Global Gadopentetate Dimeglumine API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Gadopentetate Dimeglumine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Gadopentetate Dimeglumine API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Gadopentetate Dimeglumine API Sales by Region (2021-2026) & (Tons) Table 41. Global Gadopentetate Dimeglumine API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Gadopentetate Dimeglumine API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Gadopentetate Dimeglumine API Sales Market Share in Value by Region (2021-2026) Table 44. Global Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 45. Global Gadopentetate Dimeglumine API Sales by Region (2027-2032) & (Tons) Table 46. Global Gadopentetate Dimeglumine API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Gadopentetate Dimeglumine API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Gadopentetate Dimeglumine API Sales Market Share in Value by Region (2027-2032) Table 49. Global Gadopentetate Dimeglumine API Sales (Tons), Value (US$ Million), Price (US$/K G) and Gross Margin (2027-2032) Table 50. Global Gadopentetate Dimeglumine API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (Tons) Table 52. Global Gadopentetate Dimeglumine API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Gadopentetate Dimeglumine API Sales Market Share in Value by Application (2021-2026) Table 55. Global Gadopentetate Dimeglumine API Price by Application (2021-2026) & (US$/K G) Table 56. Global Gadopentetate Dimeglumine API Sales by Application (2027-2032) & (Tons) Table 57. Global Gadopentetate Dimeglumine API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Gadopentetate Dimeglumine API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Gadopentetate Dimeglumine API Sales Market Share in Value by Application (2027-2032) Table 60. Global Gadopentetate Dimeglumine API Price by Application (2027-2032) & (US$/K G) Table 61. North America Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (Tons) Table 62. North America Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (Tons) Table 64. Europe Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (Tons) Table 68. Latin America Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Gadopentetate Dimeglumine API Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai New Hualian Pharmaceutical Company Information Table 72. Shanghai New Hualian Pharmaceutical Business Overview Table 73. Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 74. Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 75. Shanghai New Hualian Pharmaceutical Recent Development Table 76. Seven Star Pharmaceutical Company Information Table 77. Seven Star Pharmaceutical Business Overview Table 78. Seven Star Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 79. Seven Star Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 80. Seven Star Pharmaceutical Recent Development Table 81. Guangdong Xianqiang Pharmaceutical Company Information Table 82. Guangdong Xianqiang Pharmaceutical Business Overview Table 83. Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 84. Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 85. Guangdong Xianqiang Pharmaceutical Recent Development Table 86. Beijing Beilu Pharmaceutical Company Information Table 87. Beijing Beilu Pharmaceutical Business Overview Table 88. Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 89. Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio Table 90. Beijing Beilu Pharmaceutical Recent Development Table 91. Biophore Company Information Table 92. Biophore Business Overview Table 93. Biophore Gadopentetate Dimeglumine API Sales (Tons), Revenue (US$ Million), Price (US$/K G) and Gross Margin (2021-2026) Table 94. Biophore Gadopentetate Dimeglumine API Product Portfolio Table 95. Biophore Recent Development Table 96. North America Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 97. North America Gadopentetate Dimeglumine API Sales by Country (2021-2026) & (Tons) Table 98. North America Gadopentetate Dimeglumine API Sales Market Share by Country (2021-2026) Table 99. North America Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032) & (Tons) Table 100. North America Gadopentetate Dimeglumine API Sales Market Share Forecast by Country (2027-2032) Table 101. North America Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Gadopentetate Dimeglumine API Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Gadopentetate Dimeglumine API Market Share by Country (2021-2026) Table 104. North America Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Gadopentetate Dimeglumine API Market Share Forecast by Country (2027-2032) Table 106. Europe Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 107. Europe Gadopentetate Dimeglumine API Sales by Country (2021-2026) & (Tons) Table 108. Europe Gadopentetate Dimeglumine API Sales Market Share by Country (2021-2026) Table 109. Europe Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032) & (Tons) Table 110. Europe Gadopentetate Dimeglumine API Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Gadopentetate Dimeglumine API Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Gadopentetate Dimeglumine API Market Share by Country (2021-2026) Table 114. Europe Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Gadopentetate Dimeglumine API Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Gadopentetate Dimeglumine API Sales by Country (2021-2026) & (Tons) Table 118. Asia-Pacific Gadopentetate Dimeglumine API Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032) & (Tons) Table 120. Asia-Pacific Gadopentetate Dimeglumine API Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Gadopentetate Dimeglumine API Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Gadopentetate Dimeglumine API Market Share by Country (2021-2026) Table 124. Asia-Pacific Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Gadopentetate Dimeglumine API Market Share Forecast by Country (2027-2032) Table 126. Latin America Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 127. Latin America Gadopentetate Dimeglumine API Sales by Country (2021-2026) & (Tons) Table 128. Latin America Gadopentetate Dimeglumine API Sales Market Share by Country (2021-2026) Table 129. Latin America Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032) & (Tons) Table 130. Latin America Gadopentetate Dimeglumine API Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Gadopentetate Dimeglumine API Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Gadopentetate Dimeglumine API Market Share by Country (2021-2026) Table 134. Latin America Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Gadopentetate Dimeglumine API Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Gadopentetate Dimeglumine API Sales by Country (2021-2026) & (Tons) Table 138. Middle East and Africa Gadopentetate Dimeglumine API Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032) & (Tons) Table 140. Middle East and Africa Gadopentetate Dimeglumine API Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Gadopentetate Dimeglumine API Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Gadopentetate Dimeglumine API Market Share by Country (2021-2026) Table 144. Middle East and Africa Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Gadopentetate Dimeglumine API Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Gadopentetate Dimeglumine API Distributors List Table 149. Gadopentetate Dimeglumine API Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Gadopentetate Dimeglumine API Image Figure 2. Global Gadopentetate Dimeglumine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gadopentetate Dimeglumine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Gadopentetate Dimeglumine API Sales (2021-2032) & (Tons) Figure 5. Purity ≥98% Image Figure 6. Global Purity ≥98% Sales YoY Growth (2021-2032) & (Tons) Figure 7. Purity ≥99% Image Figure 8. Global Purity ≥99% Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Gadopentetate Dimeglumine API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Gadopentetate Dimeglumine API Market Share by Type 2025 VS 2032 Figure 11. North America Gadopentetate Dimeglumine API Sales Market Share in Volume by Type in 2025 Figure 12. North America Gadopentetate Dimeglumine API Sales Market Share in Value by Type in 2025 Figure 13. Europe Gadopentetate Dimeglumine API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Gadopentetate Dimeglumine API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Gadopentetate Dimeglumine API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Gadopentetate Dimeglumine API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Gadopentetate Dimeglumine API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Gadopentetate Dimeglumine API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Gadopentetate Dimeglumine API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Gadopentetate Dimeglumine API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Gadopentetate Dimeglumine API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. CNS Contrast Agent Image Figure 24. Global CNS Contrast Agent Sales YoY Growth (2021-2032) & (Tons) Figure 25. Liver Contrast Agent Image Figure 26. Global Liver Contrast Agent Sales YoY Growth (2021-2032) & (Tons) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 29. Global Gadopentetate Dimeglumine API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Gadopentetate Dimeglumine API Market Share by Application 2025 VS 2032 Figure 31. North America Gadopentetate Dimeglumine API Sales Market Share in Volume by Application in 2025 Figure 32. North America Gadopentetate Dimeglumine API Sales Market Share in Value by Application in 2025 Figure 33. Europe Gadopentetate Dimeglumine API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Gadopentetate Dimeglumine API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Gadopentetate Dimeglumine API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Gadopentetate Dimeglumine API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Gadopentetate Dimeglumine API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Gadopentetate Dimeglumine API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Gadopentetate Dimeglumine API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Gadopentetate Dimeglumine API Sales Market Share in Value by Application in 2025 Figure 41. North America Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 42. North America Gadopentetate Dimeglumine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Gadopentetate Dimeglumine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Gadopentetate Dimeglumine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. Europe Gadopentetate Dimeglumine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Gadopentetate Dimeglumine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Gadopentetate Dimeglumine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Asia-Pacific Gadopentetate Dimeglumine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Gadopentetate Dimeglumine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Gadopentetate Dimeglumine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Latin America Gadopentetate Dimeglumine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Gadopentetate Dimeglumine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Gadopentetate Dimeglumine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Gadopentetate Dimeglumine API Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Middle East and Africa Gadopentetate Dimeglumine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Gadopentetate Dimeglumine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Gadopentetate Dimeglumine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Gadopentetate Dimeglumine API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Gadopentetate Dimeglumine API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥98%
  • Purity ≥99%
Applications
  • CNS Contrast Agent
  • Liver Contrast Agent
  • Others
Companies covered
  • Shanghai New Hualian Pharmaceutical
  • Seven Star Pharmaceutical
  • Guangdong Xianqiang Pharmaceutical
  • Beijing Beilu Pharmaceutical
  • Biophore

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gadopentetate Dimeglumine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gadopentetate Dimeglumine API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Gadopentetate Dimeglumine API Market by Type
  6. 1.3.1 Purity ≥98%
  7. 1.3.2 Purity ≥99%
  8. 1.4 Global Gadopentetate Dimeglumine API Market Size by Type
  9. 1.4.1 Global Gadopentetate Dimeglumine API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Gadopentetate Dimeglumine API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Gadopentetate Dimeglumine API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Gadopentetate Dimeglumine API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Gadopentetate Dimeglumine API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Gadopentetate Dimeglumine API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Gadopentetate Dimeglumine API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Gadopentetate Dimeglumine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Gadopentetate Dimeglumine API Industry Trends
  2. 2.2 Gadopentetate Dimeglumine API Industry Drivers
  3. 2.3 Gadopentetate Dimeglumine API Industry Opportunities and Challenges
  4. 2.4 Gadopentetate Dimeglumine API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Gadopentetate Dimeglumine API Revenue (2021-2026)
  2. 3.2 Global Top Players by Gadopentetate Dimeglumine API Sales (2021-2026)
  3. 3.3 Global Top Players by Gadopentetate Dimeglumine API Price (2021-2026)
  4. 3.4 Global Gadopentetate Dimeglumine API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gadopentetate Dimeglumine API Major Company Production Sites & Headquarters
  6. 3.6 Global Gadopentetate Dimeglumine API Company, Product Type & Application
  7. 3.7 Global Gadopentetate Dimeglumine API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gadopentetate Dimeglumine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gadopentetate Dimeglumine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Gadopentetate Dimeglumine API Tier 1, Tier 2, and Tier 3
4 Gadopentetate Dimeglumine API Regional Status and Outlook
  1. 4.1 Global Gadopentetate Dimeglumine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Gadopentetate Dimeglumine API Historic Market Size by Region
  3. 4.2.1 Global Gadopentetate Dimeglumine API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Gadopentetate Dimeglumine API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Gadopentetate Dimeglumine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Gadopentetate Dimeglumine API Forecasted Market Size by Region
  7. 4.3.1 Global Gadopentetate Dimeglumine API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Gadopentetate Dimeglumine API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Gadopentetate Dimeglumine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Gadopentetate Dimeglumine API by Application
  1. 5.1 Gadopentetate Dimeglumine API Market by Application
  2. 5.1.1 CNS Contrast Agent
  3. 5.1.2 Liver Contrast Agent
  4. 5.1.3 Others
  5. 5.2 Global Gadopentetate Dimeglumine API Market Size by Application
  6. 5.2.1 Global Gadopentetate Dimeglumine API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Gadopentetate Dimeglumine API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Gadopentetate Dimeglumine API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Gadopentetate Dimeglumine API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Gadopentetate Dimeglumine API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Gadopentetate Dimeglumine API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Gadopentetate Dimeglumine API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Gadopentetate Dimeglumine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai New Hualian Pharmaceutical
  2. 6.1.1 Shanghai New Hualian Pharmaceutical Company Information
  3. 6.1.2 Shanghai New Hualian Pharmaceutical Business Overview
  4. 6.1.3 Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai New Hualian Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  6. 6.1.5 Shanghai New Hualian Pharmaceutical Recent Developments
  7. 6.2 Seven Star Pharmaceutical
  8. 6.2.1 Seven Star Pharmaceutical Company Information
  9. 6.2.2 Seven Star Pharmaceutical Business Overview
  10. 6.2.3 Seven Star Pharmaceutical Gadopentetate Dimeglumine API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Seven Star Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  12. 6.2.5 Seven Star Pharmaceutical Recent Developments
  13. 6.3 Guangdong Xianqiang Pharmaceutical
  14. 6.3.1 Guangdong Xianqiang Pharmaceutical Company Information
  15. 6.3.2 Guangdong Xianqiang Pharmaceutical Business Overview
  16. 6.3.3 Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Guangdong Xianqiang Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  18. 6.3.5 Guangdong Xianqiang Pharmaceutical Recent Developments
  19. 6.4 Beijing Beilu Pharmaceutical
  20. 6.4.1 Beijing Beilu Pharmaceutical Company Information
  21. 6.4.2 Beijing Beilu Pharmaceutical Business Overview
  22. 6.4.3 Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beijing Beilu Pharmaceutical Gadopentetate Dimeglumine API Product Portfolio
  24. 6.4.5 Beijing Beilu Pharmaceutical Recent Developments
  25. 6.5 Biophore
  26. 6.5.1 Biophore Company Information
  27. 6.5.2 Biophore Business Overview
  28. 6.5.3 Biophore Gadopentetate Dimeglumine API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Biophore Gadopentetate Dimeglumine API Product Portfolio
  30. 6.5.5 Biophore Recent Developments
7 North America by Country
  1. 7.1 North America Gadopentetate Dimeglumine API Sales by Country
  2. 7.1.1 North America Gadopentetate Dimeglumine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Gadopentetate Dimeglumine API Sales by Country (2021-2026)
  4. 7.1.3 North America Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Gadopentetate Dimeglumine API Market Size by Country
  6. 7.2.1 North America Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Gadopentetate Dimeglumine API Market Size by Country (2021-2026)
  8. 7.2.3 North America Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Gadopentetate Dimeglumine API Sales by Country
  2. 8.1.1 Europe Gadopentetate Dimeglumine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Gadopentetate Dimeglumine API Sales by Country (2021-2026)
  4. 8.1.3 Europe Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Gadopentetate Dimeglumine API Market Size by Country
  6. 8.2.1 Europe Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Gadopentetate Dimeglumine API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Gadopentetate Dimeglumine API Sales by Country
  2. 9.1.1 Asia-Pacific Gadopentetate Dimeglumine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Gadopentetate Dimeglumine API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Gadopentetate Dimeglumine API Market Size by Country
  6. 9.2.1 Asia-Pacific Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Gadopentetate Dimeglumine API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Gadopentetate Dimeglumine API Sales by Country
  2. 10.1.1 South America Gadopentetate Dimeglumine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Gadopentetate Dimeglumine API Sales by Country (2021-2026)
  4. 10.1.3 South America Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Gadopentetate Dimeglumine API Market Size by Country
  6. 10.2.1 South America Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Gadopentetate Dimeglumine API Market Size by Country (2021-2026)
  8. 10.2.3 South America Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Gadopentetate Dimeglumine API Sales by Country
  2. 11.1.1 Middle East and Africa Gadopentetate Dimeglumine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Gadopentetate Dimeglumine API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Gadopentetate Dimeglumine API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Gadopentetate Dimeglumine API Market Size by Country
  6. 11.2.1 Middle East and Africa Gadopentetate Dimeglumine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Gadopentetate Dimeglumine API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Gadopentetate Dimeglumine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Gadopentetate Dimeglumine API Value Chain Analysis
  2. 12.1.1 Gadopentetate Dimeglumine API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Gadopentetate Dimeglumine API Production Mode & Process
  7. 12.2 Gadopentetate Dimeglumine API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Gadopentetate Dimeglumine API Distributors
  10. 12.2.3 Gadopentetate Dimeglumine API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst